BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33722259)

  • 1. PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways.
    Uzozie AC; Ergin EK; Rolf N; Tsui J; Lorentzian A; Weng SSH; Nierves L; Smith TG; Lim CJ; Maxwell CA; Reid GSD; Lange PF
    J Exp Clin Cancer Res; 2021 Mar; 40(1):96. PubMed ID: 33722259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first Japanese biobank of patient-derived pediatric acute lymphoblastic leukemia xenograft models.
    Tanaka K; Kato I; Dobashi Y; Imai JI; Mikami T; Kubota H; Ueno H; Ito M; Ogawa S; Nakahata T; Takita J; Toyoda H; Ogawa C; Adachi S; Watanabe S; Goto H
    Cancer Sci; 2022 Nov; 113(11):3814-3825. PubMed ID: 35879192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Casein Kinase II inhibition and epigenetic modulation in acute B-lymphoblastic leukemia.
    Richter A; Roolf C; Hamed M; Gladbach YS; Sender S; Konkolefski C; Knübel G; Sekora A; Fuellen G; Vollmar B; Murua Escobar H; Junghanss C
    BMC Cancer; 2019 Mar; 19(1):202. PubMed ID: 30841886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia.
    Xie J; Span M; van Maarseveen E; Langenhorst J; Boddy AV; Sia KCS; Sutton R; Venn N; Punt AM; Tyrrell V; Haber M; Trahair T; Lau L; Marshall GM; Lock RB
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28133. PubMed ID: 31876116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Zhang S; Lin W; Cao Y; Xu F; Fang Y; Wang Z; Zhang H; Li X; Wang Z; Cai J; Wang J; Zhang Y; Mao X; Zhao W; Hu S; Chen S; Wang J
    Haematologica; 2015 Mar; 100(3):345-56. PubMed ID: 25512644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cross-standardized flow cytometry platform to assess phenotypic stability in precursor B-cell acute lymphoblastic leukemia (B-ALL) xenografts.
    Rolf N; Liu LYT; Tsang A; Lange PF; Lim CJ; Maxwell CA; Vercauteren SM; Reid GSD
    Cytometry A; 2022 Jan; 101(1):57-71. PubMed ID: 34128309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
    Rokita JL; Rathi KS; Cardenas MF; Upton KA; Jayaseelan J; Cross KL; Pfeil J; Egolf LE; Way GP; Farrel A; Kendsersky NM; Patel K; Gaonkar KS; Modi A; Berko ER; Lopez G; Vaksman Z; Mayoh C; Nance J; McCoy K; Haber M; Evans K; McCalmont H; Bendak K; Böhm JW; Marshall GM; Tyrrell V; Kalletla K; Braun FK; Qi L; Du Y; Zhang H; Lindsay HB; Zhao S; Shu J; Baxter P; Morton C; Kurmashev D; Zheng S; Chen Y; Bowen J; Bryan AC; Leraas KM; Coppens SE; Doddapaneni H; Momin Z; Zhang W; Sacks GI; Hart LS; Krytska K; Mosse YP; Gatto GJ; Sanchez Y; Greene CS; Diskin SJ; Vaske OM; Haussler D; Gastier-Foster JM; Kolb EA; Gorlick R; Li XN; Reynolds CP; Kurmasheva RT; Houghton PJ; Smith MA; Lock RB; Raman P; Wheeler DA; Maris JM
    Cell Rep; 2019 Nov; 29(6):1675-1689.e9. PubMed ID: 31693904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
    Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
    Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.
    Jing D; Bhadri VA; Beck D; Thoms JA; Yakob NA; Wong JW; Knezevic K; Pimanda JE; Lock RB
    Blood; 2015 Jan; 125(2):273-83. PubMed ID: 25336632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia.
    Richter-Pechańska P; Kunz JB; Bornhauser B; von Knebel Doeberitz C; Rausch T; Erarslan-Uysal B; Assenov Y; Frismantas V; Marovca B; Waszak SM; Zimmermann M; Seemann J; Happich M; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Muckenthaler MU; Korbel JO; Bourquin JP; Kulozik AE
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30389682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The photosensitizer verteporfin has light-independent anti-leukemic activity for Ph-positive acute lymphoblastic leukemia and synergistically works with dasatinib.
    Morishita T; Hayakawa F; Sugimoto K; Iwase M; Yamamoto H; Hirano D; Kojima Y; Imoto N; Naoe T; Kiyoi H
    Oncotarget; 2016 Aug; 7(35):56241-56252. PubMed ID: 27494842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts.
    El-Hoss J; Jing D; Evans K; Toscan C; Xie J; Lee H; Taylor RA; Lawrence MG; Risbridger GP; MacKenzie KL; Sutton R; Lock RB
    Oncotarget; 2016 Sep; 7(37):60475-60490. PubMed ID: 27528024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targetable lesions and proteomes predict therapy sensitivity through disease evolution in pediatric acute lymphoblastic leukemia.
    Lorentzian AC; Rever J; Ergin EK; Guo M; Akella NM; Rolf N; James Lim C; Reid GSD; Maxwell CA; Lange PF
    Nat Commun; 2023 Nov; 14(1):7161. PubMed ID: 37989729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
    Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
    Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
    Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
    Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic Leukemia.
    Pierro J; Saliba J; Narang S; Sethia G; Saint Fleur-Lominy S; Chowdhury A; Qualls A; Fay H; Kilberg HL; Moriyama T; Fuller TJ; Teachey DT; Schmiegelow K; Yang JJ; Loh ML; Brown PA; Zhang J; Ma X; Tsirigos A; Evensen NA; Carroll WL
    Mol Cancer Res; 2020 Aug; 18(8):1153-1165. PubMed ID: 32332049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy collaborates with ubiquitination to downregulate oncoprotein E2A/Pbx1 in B-cell acute lymphoblastic leukemia.
    Yuan N; Song L; Lin W; Cao Y; Xu F; Liu S; Zhang A; Wang Z; Li X; Fang Y; Zhang H; Zhao W; Hu S; Wang J; Zhang S
    Blood Cancer J; 2015 Jan; 5(1):e274. PubMed ID: 25615280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening of human leukemia xenografts to identify dexamethasone sensitizers.
    Toscan CE; Failes T; Arndt GM; Lock RB
    J Biomol Screen; 2014 Dec; 19(10):1391-401. PubMed ID: 25104793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.